Eli Lilly Says Canada Patent Ruling Violates NAFTA

Eli Lilly Says Canada Patent Ruling Violates NAFTA | Corporate Counsel

 

Eli Lilly & Co. told an international trade body that Canada violated international law when it invalidated two of its key patents. The company said the invalidation by Canadian courts of patents for two Lilly drugs—Zyprexa, used in the treatment of schizophrenia; and Strattera, used to treat Attention Deficit Hyperactivity Disorder (ADHD)—is illegal and “constitutes an uncompensated expropriation,” according to the memorial it filed with the U.N. Commission on International Trade Law and the North American Free Trade Agreement.